Stanifer et al. JASN May 15, 2017 After a series of trials which included individuals receiving dialysis, the benefit of statin-based therapies as eGFR declines, particularly to the point of requiring renal-replacement therapy, has been uncertain (link, link)….
What would you do if you had chronic pain and a GFR of 90? Would you think twice about a two-month (or longer) course of NSAIDs? What if your GFR was 60? Or 30? As society grows increasingly…
The May webisode of the Renal Pathology Series from Washington University is presented in CPC style format. Walk through some differentials and interpret the histology as you piece this case together!
Jordan Weinstein (UKidney) has done it again. UKidney has assembled a great collection of high impact articles. What I love about UKidney is the organization and the style. If you are interested in learning more about a particular…
One of the sessions that caught my attention at the 2017 NKF Spring Clinical Meeting in Orlando, Florida was “Beyond RAAS Inhibitors: Novel Drugs for Diabetic Kidney Disease” by Katherine Tuttle,MD. There was a lot of hype around…
Recently, a young man was admitted to the ICU. He had recently been diagnosed with recurrent cancer and had received a single dose of dexamethasone the previous night. He had taken double the prescribed dose because he had…
I ran into a colleague from Children’s Hospital over the weekend and she pointed me in the direction of this great education website that they have created for the education of students, residents and fellows. In particular, they…
In patients with combined renal and liver dysfunction it is important to differentiate between renal impairment that is secondary to liver disease i.e. hepatorenal syndrome, and conditions where an insult directly affects both the liver and kidney. …
CMV infection still remains one of the most common and unpredictable complications in transplant recipients, and the negative consequences in terms of graft lost and recipient survival are well known. In this setting, I would like to present…
A patient has an elevated intracranial pressure (ICP) and is also markedly hypertensive. You are faced with a dilemma?? Which antihypertensive agents would be preferred in a patient with known elevated intracranial pressure? Should we even be trying…